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Objectives To determine the outcomes of medical management, pacing, and catheter ablation for the treatment of
nonpost-operative junctional ectopic tachycardia (JET) in a pediatric population.
Background Nonpost-operative JET is a rare tachyarrhythmia that is associated with a high rate of morbidity and mortality.
Most reports of clinical outcomes were published before the routine use of amiodarone or ablation therapies.
Methods This is an international, multicenter retrospective outcome study of pediatric patients treated for nonpost-operative JET.
Results A total of 94 patients with JET and 5 patients with accelerated junctional rhythm (age 0.8 year, range fetus to
16 years) from 22 institutions were identified. JET patients presenting at age 6 months were more likely to
have incessant JET and to have faster JET rates. Antiarrhythmic medications were utilized in a majority of JET
patients (89%), and of those, amiodarone was the most commonly reported effective agent (60%). Radiofre-
quency ablation was conducted in 17 patients and cryoablation in 27, with comparable success rates (82% ra-
diofrequency vs. 85% cryoablation, p  1.0). Atrioventricular junction ablation was required in 3% and pace-
maker implantation in 14%. There were 4 (4%) deaths, all in patients presenting at age 6 months.
Conclusions Patients with nonpost-operative JET have a wide range of clinical presentations, with younger patients demonstrating
higher morbidity and mortality. With current medical, ablative, and device therapies, the majority of patients have a good
clinical outcome. (J Am Coll Cardiol 2009;53:690–7) © 2009 by the American College of Cardiology Foundation
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February 24, 2009:690–7 Nonpost-Operative JET in Pediatricsunctional ectopic tachycardia (JET) not associated with
ardiac surgery is a rare arrhythmia that can present at any
ge (1). The mechanism of the tachycardia is thought to be
bnormal automaticity arising from the region of the atrio-
entricular junction. Congenital JET presents in infancy
nd is associated with high morbidity and mortality (1–7).
ET presenting beyond the first 6 months of life has a
ariable presentation. Most data concerning the treatment
f JET are from single-center case reports and small case
eries (1–6,8–21). The most recent multicenter study on
ET was published in 1990 (5), just as amiodarone was
eginning to gain widespread use and before the era of
atheter ablation as curative therapy. In addition, with
mproved technology for evaluation of the fetus, JET can
ow be diagnosed in utero, with the goal of earlier therapy
nd potentially improved outcome (15,22).
The purpose of this study is to describe outcomes of
ediatric patients treated for JET, specifically addressing
fficacy and safety of medical management, pacing, and
atheter ablation.
ethods
atient population. This is an international, multicenter
etrospective review of nonpost-operative junctional tachy-
ardias from the Pediatric and Congenital Electrophysiol-
gy Society. Approval for medical chart review was obtained
rom the Institutional Review Board at each institution. All
atients 18 years of age evaluated and treated with the
iagnosis of nonpost-operative JET or accelerated junc-
ional rhythm (AJR) were included. Patients had either a
ormal structural heart or only minor cardiac defects that
id not require cardiac surgery.
The diagnosis of JET was based on clinical, noninvasive
valuation of the patient by the attending electrophysiolo-
ist, using established electrocardiographic criteria (1,5) in
ddition to JET rate criteria (23,24). JET was defined as a
achycardia originating from the atrioventricular junction
ith gradual onset, gradual offset, and rate variability. The
ollowing features were observed: 1) a narrow QRS complex
ith either atrioventricular dissociation and sinus capture
eats or 1:1 V:A association; or 2) a wide QRS complex
ith atrioventricular dissociation and sinus capture beats
ith the same wide QRS complex noted during tachycardia,
he sinus capture beats, or sinus rhythm. JET was further
efined by a junctional rate 95th percentile of heart rate
Demographics of Pediatric Patients With JET an
Table 1 Demographics of Pediatric Patients
All Patients
Number 99
Male 58 (59%)
Median age, yrs (range) 0.8 (fetus–16)
Age at presentation
6 months 47 (47%)
6 months 52 (53%)AJR  accelerated junctional rhythm; JET  junctional ectopic tachycardia.or age (23,24). Patients with
unctional rates 95th percentile
ere reported as having AJR.
ET frequency on presentation
as classified as incessant (a con-
istent tachycardia without con-
ersion to sinus rhythm), sus-
ained (JET occurring 50% of
he time), or sporadic (predomi-
antly sinus rhythm with episodic JET).
ata collection. Medical charts were reviewed for the
ollowing: age at presentation, symptoms, family history of
ET, antiarrhythmic therapies, details of radiofrequency
RF), or cryoablation procedures, the placement of a per-
anent pacemaker or defibrillator, and clinical outcomes.
he finding of spontaneous atrioventricular block was
ecorded (10).
tatistical analysis. Data are presented as median (range).
hi-square and Fisher exact tests were utilized for categor-
cal variables. The Wilcoxon rank sum test was used for
onparametric comparisons of continuous variables. Linear
egression was utilized for the evaluation of JET rate as a
unction of patient age.
esults
atient population. The study population consisted of 94
atients with JET and 5 patients with AJR from 22
nstitutions (Table 1). Several patients have been described
reviously (8,9,14,17,21). The median year of presentation
as 2001 (1969 to 2008), with only 6 patients presenting
efore the availability of RF ablation. A familial association
as noted in 20% of patients. The presence of maternal
upus antibodies was not routinely evaluated; however, 1
other was known to be anti-Rho and anti-La positive.
inor heart defects were diagnosed in 24%, including 16
atent foramen ovale, 1 muscular ventricular septal defect, 4
atent ductus arteriosis, and 3 mitral valve prolapse.
atients with accelerated AJR. The presenting symptom
f patients with AJR was a rapid or irregular heart rate in 4
nd unknown in 1. Rates of AJR were median 120 beats/
in (117 to 170 beats/min). All 5 patients were given a trial
f antiarrhythmic medications including digoxin (n  3),
tenolol (n  2), verapamil (n  1), and propafenone (n 
). At last follow-up, all patients are doing well on no
ntiarrhythmic medications. One patient had rapid shift of
Abbreviations
and Acronyms
AJR  accelerated
junctional rhythm
JET  junctional ectopic
tachycardia
RF  radiofrequency
JET and AJR
JET AJR
94 5
56 (60%) 2 (40%)
0.9 (fetus–16) 0.8 (birth–7)
44 (47%) 3 (60%)
50 (53%) 2 (40%)d AJR
With
c
a
p
t
t
i
O
a
P
a
m
(
r
e
w
d
s
i
s
m
3
(
(
i
v
v
u
3
A
a
o
a
w
t
a
(
c
t
i
a
(
h
692 Collins et al. JACC Vol. 53, No. 8, 2009
Nonpost-Operative JET in Pediatrics February 24, 2009:690–7ardiac rhythm from AJR to complete atrioventricular block
nd required the placement of a permanent pacemaker. One
atient had 2 cryoablation procedures, with no further
achycardia. Two patients had spontaneous resolution of
heir AJR, 1 after 2 electrophysiology studies without
nducible tachycardia and with no ablation being performed.
ne patient continues to have episodic AJR but is
symptomatic.
atients with JET. Patient age on presentation of JET was
lmost evenly divided between 6 months of life and 6
onths of life (Table 1). Symptoms on presentation varied
Fig. 1). The majority of patients (60%; 56 of 94) had a
apid or irregular heart rate sensed by the patient or
valuated on physical examination. Congestive heart failure
as found in 16% (15 of 94). Fetal tachycardia was
iagnosed in 17% (16 of 94), with 4 of these patients having
igns of hydrops.
JET frequency on presentation was more likely to be
ncessant in patients presenting at 6 months of age and
poradic for those presenting at 6 months (Fig. 2). The
edian JET rate on presentation was 209 beats/min (136 to
20 beats/min) and tended to be higher in younger patients
Fig. 3). Only 2 patients had a wide complex tachycardia
QRS 150 ms), which was diagnosed as JET during an
nvasive electrophysiology study. The relationship between
entricular and atrial contractions during tachycardia was
entricular-atrial dissociated in 56% (53 of 94), 1:1 ventric-
lar/atrial relationship in 32% (30 of 94), periods of both in
% (3 of 94), and not documented in 9% (8 of 94).
ntiarrhythmic medications in patients with JET. Anti-
rrhythmic medications were the initial therapy in 89% (84
f 94). Six patients (6%) with JET were monitored clinically
nd never required therapy. In these patients, JET rates
ere 140 to 211 beats/ min, and JET was episodic in 5 of
Figure 1 Presenting Signs or Symptoms for Nonpost-Operative
The presenting signs or symptoms are shown for 94 pediatric patients with nonpo
red  heart failure; orange  fetal tachycardia with hydrops; yellow  fetal tachyche 6 patients. Another 4 (4%) patients underwent an
blation procedure as first-line therapy.
A wide variety of antiarrhythmic medications was utilized
Table 2). The majority of patients (62%; 52 of 84) required
oncomitant administration of 2 antiarrhythmic medica-
ions. Medications resulted in complete suppression of JET
n only 11% (9 of 84). More commonly, medications were
ssociated with a decrease in JET rate or frequency in 70%
59 of 84). In the remaining 19% (16 of 84), medications
ad no effect. Of the antiarrhythmic agents reported as
Rapid or irregular heart rate
Heart failure
Fetal tachycardia with hydrops
Fetal tachycardia without hydrops
Screening electrocardiogram
syncope
ional Ectopic Tachycardia
rative junctional ectopic tachycardia. Blue  rapid or irregular heart rate;
without hydrops; pink  screening electrocardiogram; lavender  syncope.
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Figure 2 Frequency of JET on Presentation
This graph depicts the number of patients with incessant, sporadic, and epi-
sodic junctional ectopic tachycardia (JET). The bars are further divided by age
at presentation of 6 months (blue area) and 6 months (pink area).
Patients who were age 6 months were more likely to have incessant JET,
whereas patients age 6 months were more likely to have episodic JET (p 
0.0001).Junct
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February 24, 2009:690–7 Nonpost-Operative JET in Pediatricsuccessfully affecting the rate or frequency of JET, amioda-
one alone or in combination was the most frequently cited
edication, at 60% (41 of 68) (Table 3).
blation therapy for JET. Of the patients with JET, 49
atients underwent invasive electrophysiology studies with
he intention of catheter ablation of the junctional focus,
ith 10 patients requiring more than 1 procedure. Radio-
requency ablation of JET was performed in 17 and cryoa-
lation in 26 patients. Other procedures included both RF
nd cryoablation of JET at the same procedure (n  2), RF
blation for an accessory pathway (n  2), and electrophys-
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Figure 3 JET Rate on Presentation
as Function of Patient Age
This graph shows the relationship of junctional ectopic tachycardia (JET) rate
(beats/min) on presentation with the patient’s age (years) at presentation.
Patients who presented at a younger age had higher JET rates (r2  0.232,
p  0.0001).
ntiarrhythmic Medicationstil zed for the Tr atment of JET
Table 2 Antiarrhythmic MedicationsUtilized for the Treatment of JET
Medication No. of Patients on Medication
Beta-blockers 53
Atenolol 20
Carvedilol 1
Esmolol 6
Metoprolol 2
Propranolol 24
Amiodarone 50
Digoxin 44
Flecainide 22
Procainamide 11
Sotalol 11
Propafenone 6
Verapamil 5
Lidocaine 4
Diphenylhydantoin 1
Mexiletine 1
Quinidine 1pET  junctional ectopic tachycardia.ology study without ablation (n  2). Catheter ablation of
he atrioventricular junction was performed in 3 patients, 1
s a primary procedure and 2 after JET recurrences. Two
atients had ablation for atypical atrioventricular nodal
eentrant tachycardia, 1 at the same procedure as JET and 1
s an initial procedure with JET diagnosed later in the
ourse.
Data comparing RF ablation to cryoablation reflect infor-
ation for the first ablation procedure performed at the
nstitution. In the cryoablation group, the 1 patient with AJR
nd cryoablation is also included in the analysis (Table 4). The
ndication for ablation was largely heart failure or refractory
ET for patients undergoing RF ablation and elective for
hose undergoing cryoablation. A 3-dimensional mapping
ystem was utilized in 4 patients with cryoablation. Radio-
requency or cryoablation lesions were placed during sinus
r atrial-paced rhythm in approximately one-third of the
atients and in JET for two-thirds. Cryoablation catheter
ip size was evenly divided between a 4- and 6-mm tip. A
reeze-thaw-freeze was utilized in 7 patients.
Initial success (82% to 85%) and recurrence rates (13% to
4%) were similar for RF and cryoablation. In 2 patients
ho received both RF and cryoablation during the same
rocedure, 1 had JET recurrence and the other has been
achycardia-free. Inadvertent permanent third-degree atrio-
entricular block occurred in 3 of 17 (18%) patients who
nderwent RF ablation. There was no permanent atrioven-
ricular block with cryoablation. Transient third-degree
trioventricular block occurred in 1 patient with RF ablation
nd in 5 patients with cryoablation (1 after a successful
ryomapping).
ermanent pacemakers in patients with JET. Permanent
edications Reported to beuccessful in the Tr atment of JET
Table 3 Medications Reported to beSuccessful in the Treatment of JET
Medication Number of Patients
Amiodarone (total) 41
As a single agent 20
Plus beta-blocker 6
Plus digoxin 3
Plus digoxin plus procainamide 5
Plus digoxin plus beta-blocker 1
Plus flecainide 4
Plus propafenone 2
Digoxin 1
Beta-blocker 9
Digoxin plus beta-blocker 2
Flecainide 3
Flecainide plus verapamil 1
Propafenone 1
Propafenone plus digoxin 1
Sotalol 2
Procainamide 1
Not specified 6
Total 68
ET  junctional ectopic tachycardia.acing systems were placed in 14% (13 of 94) patients.
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Nonpost-Operative JET in Pediatrics February 24, 2009:690–7omplete atrioventricular block was the indication for
acing in 10 patients: 3 subsequent to ablation of the
trioventricular junction, 4 secondary to inadvertent atrio-
entricular block during RF ablation with their initial or
ubsequent procedure, and 3 with spontaneous atrioventric-
lar block. The remaining 3 patients had a placement of a
ermanent pacemaker for the following indications: 1 had a
acemaker implanted at age 5 weeks for “back-up” pacing,
nd this was explanted 10 years later; 1 had sinus bradycar-
ia on antiarrhythmic therapy; and 1 had a possible asystolic
ardiac arrest.
omorbidities and complications in patients with JET. Co-
orbidities or complications were reported for 13 patients
uring their treatment for JET and none for patients with
JR (Table 5). One of the patients had sustained a cardiac
rrest and had an implantable cardioverter-defibrillator
laced at age 9 years; this was a patient with possible
yocarditis.
utcomes of patients with JET. Patients were followed
p for a median of 4.5 years (range 0.03 to 28 years). Most
atients (75%; 70 of 94), were doing well on no current
herapy for JET. These patients included 32 with successful
blation procedures, 21 with spontaneous resolution of the
ET, 11 with continued JET but with acceptable heart rates,
nd 6 with permanent pacing and no further JET. Those
utcomes of Radiofrequency Ablation and Cryoablation for Junction
Table 4 Outcomes of Radiofrequency Ablation and Cryoablation
Radiofr
n 1
Year of ablation 2002 (19
Age, yrs 7 (0.0
Ablation indication
Heart failure, JET, medications unsuccessful
Refractory JET, medications unsuccessful 1
Medication side effects
Elective
General anesthesia 12 (71
JET during electrophysiology study
Spontaneous 1
Inducible
None
JET frequency during electrophysiology study
Incessant
Sustained 1
Nonsustained
Isuprel needed for JET 6 (38
Fluoroscopy time, min 9 (3–
Procedure time, min 151 (45
Ablation lesions, n 4 (1–
Total duration of ablation lesions, s 145 (11
Initial success 14 (82
Transient third-degree AV block 1 (6%
Inadvertent permanent third-degree AV block 3 (18
Recurrence after an initially successful procedure 2/14 (14
ata are presented as median (range) or n (%). *Cryoablation group includes 26 patients with jun
AV  atrioventricular; JET  junctional ectopic tachycardia.reated with medications alone were able to be weaned off Jhe medications after a median duration of 3 years (range
.2 to 10 years).
Twenty patients (21%) continued antiarrhythmic ther-
py, but with simplification of their medical regimens.
atients remained on regimens of amiodarone (n  7),
miodarone plus beta-blocker (n  2), amiodarone plus
ecainide (n  1), beta-blocker (n  4), digoxin (n  3),
chycardias
Junctional Tachycardias
cy Cryoablation* p Value
27
08) 2006 (2003–2008) 0.0001
9 (2.4–36) 0.31
0.003
2
7
2
12
22 (82%) 0.47
20 0.57
6
1
9 0.18
10
7
8 (31%) 0.74
14 (2–50) 0.28
165 (20–362) 0.69
7 (1–67) 0.62
1,247 (240–4,472) 0.0004
23 (85%) 1.00
5 (18%)
0 0.05
3/23 (13%) 1.00
ectopic tachycardia and 1 with accelerated junctional rhythm.
omorbidities or Complicationsuring the Treatment of Patients With JET
Table 5 Comorbidities or ComplicationsDuring the Treatment of Patients With JET
Comorbidity or Complication Number
Patients presenting age 6 months
Cardiac arrest 2
Possible myocarditis 1
Prematurity 1
Extracorporeal membrane oxygenation 1
Hemopericardium after transvenous pacemaker implant 1
Possible lung hypoplasia and copious ascites 1
Short gut syndrome from arrest bowel ischemia 1
Tuberous sclerosis 1
Vitamin D deficiency, rickets 1
Insulin-dependent diabetes and hypertension 1
Patients presenting age 6 months
Cardiac arrest, possible myocarditis 1
Postural orthostatic tachycardia syndrome 1al Ta
for
equen
7
89–20
5–38)
5
0
0
2
%)
0
6
1
5
0
1
%)
195)
–220)
32)
–647)
%)
)
%)
%)ET  junctional ectopic tachycardia.
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February 24, 2009:690–7 Nonpost-Operative JET in Pediatricseta-blocker plus digoxin (n  2), flecainide plus digoxin
n  1), and propafenone plus digoxin (n  1).
eaths. Death occurred in 4 (4%) patients, all of whom
resented with JET at age 6 months. The presenting JET
ate was 205 to 270 beats/ min. Two infants died at 1
eek of age after presenting with fetal tachycardia and
ydrops. A third patient died at age 11 months with
omplications from heart failure. The fourth infant died
uddenly at age 7 months. After a prenatal diagnosis, his
ET rate was well controlled on amiodarone and digoxin.
aboratory evaluation indicated hypocalcemia and vitamin
deficiency rickets, for which he was being treated. His
udden death suggested the possibility that electrolyte im-
alances in addition to the antiarrhythmic medications
ould have provoked an acute lethal arrhythmia.
iscussion
his international multicenter study documents the out-
omes of 94 pediatric patients with nonpost-operative JET
nd 5 patients with AJR. To our knowledge, this is the
argest published series that reflects the current era manage-
ent strategies for this problem. As in previous smaller
eries, JET continues to be difficult to treat. Patient out-
omes, however, have improved with medical management
primarily amiodarone), permanent pacing, RF ablation,
nd cryoablation. Interventions such as ablation of the
trioventricular junction were required less frequently than
n prior reports.
efinition of JET versus AJR. The mechanism of JET is
hought to be an automatic focus originating at or near the
trioventricular junction. Junctional rates can be quite vari-
ble, and range from AJR to the more rapid JET. In review
f prior literature pertaining to nonpost-operative JET,
here appears to be no specific heart rate cut-off for the
iagnosis of AJR versus JET (3–5,14,17). In creating a
recise definition of JET for this manuscript, a survey of the
uthors was conducted with 3 proposed definitions for JET
ersus AJR based on prior studies in similar but different
achyarrhythmias: 1) JET defined by a junctional rate
95th percentile of heart rate for age; this definition was
tilized in a study of the efficacy of amiodarone in a largely
ost-operative congenital heart disease population (24);
) JET defined by a junctional rate of 170 beats/min; this
efinition was utilized in a study evaluating the treatment of
ET in the post-operative congenital heart disease popula-
ion (25); or 3) JET defined by 10% to 20% of the
urrounding sinus heart rate; this type of definition was
tilized to differentiate accelerated ventricular rhythm from
entricular tachycardia (26). Ultimately, the authors agreed
pon the definition of JET that included 95th percentile
f heart rate because it factored in both tachycardia rate and
atient age and also had clinical significance, with patients
aving AJR likely being less affected than those with JET.
linical outcomes comparison with prior reports. Theargest prior report of nonpost-operative JET was published Wy Villain et al. (5) and described 26 infants with JET
etween 1970 and 1987. In that article, atrioventricular
unction ablation was performed in 23%, pacemakers were
laced in 15%, and death occurred in 35%. In comparison,
ur patients had improved clinical courses, with atrioven-
ricular junction ablation performed in only 3%, a similar
umber of pacemaker placements at 14%, and a lower risk of
eath at 4%. There are, however, several differences in the
atient populations. In the prior study (5), only infants age
6 months were included. Of these, 61% had decreased
entricular function and congestive heart failure. Secondary
o the different eras of the studies, none of the patients in
hat study had RF or cryoablation for JET. Also, several of
he atrioventricular junction ablations were completed sur-
ically. In the present study, we included all patients 18
ears of age who were diagnosed with JET. Only 20%
resented with decreased ventricular function or hydrops
econdary to fetal tachycardia.
Consistent with the study by Villian et al. (5) is the
ndings that patients who present at age 6 months are
ore likely to have incessant JET and faster JET rates.
hese youngest patients were also more likely to have
ssociated comorbidities and a higher risk of death. At last
ollow-up, 75% of the patients in the current study were
oing well on no medications for JET. This outcome is
rimarily due to ablative therapies, but also includes cases of
pontaneous remission and patients in whom the JET
ersists at a slower rate that is not causing clinical symptoms
r hemodynamic compromise. A smaller case series (3)
eported 9 patients with JET, all of whom presented at age
6 months with incessant JET and were able to be
edically managed. Despite a long follow-up period of 3 to
1 years, none was able to be weaned from medications.
hile there may be some differences in patient population
etween the prior studies and ours, the differences in
utcomes may likely be due to the more widespread use of
miodarone and the advancement in ablative technologies.
ntiarrhythmic medications. Reflecting the difficulties in
reating JET and the multicenter nature of the present
tudy, patients were prescribed a variety of antiarrhythmic
herapies. Many patients required 2 medications, either
equentially or in combination, to eventually see a salutary
rug effect on JET rate. As in prior studies, our findings
upport the use of amiodarone for the treatment of JET
3,5). For patients for whom medications were thought to
e effective for tachycardia conversion or rate control,
miodarone was the most frequently cited medication. Still,
any patients required amiodarone in combination with a
econd agent.
blation. The first reported RF catheter ablation in a child
as in 1990 (21), in a patient with JET who had an initial
uccessful ablation but required subsequent atrioventricular
unction ablation. Subsequently, other case reports have
hown successful ablation of JET with preservation of
trioventricular nodal conduction (2,8,11–13,18–21,27,28).ith radiofrequency ablation in close proximity to the
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Nonpost-Operative JET in Pediatrics February 24, 2009:690–7ormal conduction system, however, there remains a signif-
cant risk of complete atrioventricular block, which would
equire the placement of a permanent pacing system. In the
ulticenter Prospective Assessment After Pediatric Cardiac
blation study (29), only 9 cases of RF ablation of JET were
eported in the “not cohort-eligible” registry. In these
atients, there was a 100% success rate and an 11% rate of
trioventricular block. By comparison, in the present study,
7 patients underwent RF ablation for JET, with an initial
uccess rate of 82% and a risk of inadvertent atrioventricular
lock of 18% (3 of 17).
In the early 2000s, catheter cryoablation became available
s an alternative energy source to RF ablation. Cryoablation
as specific advantages of increased safety when used near
he normal conduction system. Previously, cryoablation of
ET has been reported in 8 pediatric patients (14,17,30),
ith an initial success rate of 100% and no reported
nadvertent atrioventricular block. In the present study, 27
atients have undergone cryoablation procedures for JET.
hen compared with RF ablation, cryoablation was more
ikely to be an elective procedure in patients with sporadic or
ustained JET. Cryoablation resulted in an initial success
ate of 85%, with no atrioventricular block. The recurrence
ate for both RF ablation and cryoablation of JET were
imilar at 13% to 14%.
Intentional atrioventricular junction ablation was performed
nfrequently in our JET population. Only 3 patients underwent
his treatment, and these were earlier in the study. Unlike prior
eports of JET therapy, the atrioventricular junction ablations
ere carried out with a transcatheter technique.
The patients in the present report appeared to benefit
ignificantly from ablation procedures. While the choice
etween RF ablation and cryoablation should be at the
iscretion of the electrophysiologist, it seems prudent to err
n the side of safety with cryoablation technology.
acemakers and atrioventricular block. A total of 14% of
atients in the present study required permanent pacemakers.
his outcome is similar to that in the 1990 study by Villain et
l. (5). In our patients, the indication for pacing was largely
trioventricular block secondary to RF ablation of JET or
trioventricular junction ablation. Only a few patients had
pontaneous atrioventricular block. Dubin et al. (10) described
possible association between congenital JET and congenital
trioventricular block with anti-Ro and anti-La antibodies in
he mother. In our population, the history of maternal lupus or
aternal anti-lupus antibodies was largely unknown.
eaths. The mortality rate for JET has been previously
eported by Villain et al. (5) to be 34%, with 2 of 9 being
udden unexplained deaths in infants thought to have the
ET rate controlled with medications. In contrast, Cilliers
t al. (3) showed no deaths among 9 patients with JET. In
ur population, we report a 4% mortality; all deaths oc-
urred among patients presenting at age 6 months. Only
death was sudden and may have been secondary to
ossible electrolyte imbalances in a patient being treated
ith antiarrhythmic agents.tudy limitations. This was a retrospective review, with
ssociated biases of retrospective studies. Among the 22
nstitutions, there was no standard approach to JET man-
gement. With medical management, the dose and duration
f therapies were not specifically recorded.
onclusions
his international multicenter study of nonpost-operative
ET in pediatric patients demonstrates improved outcomes
ith the current available therapies of medical management
primarily amiodarone), permanent pacing, RF ablation,
nd cryoablation.
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